These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11332203)
1. The role of fibronectin in bronchoalveolar lavage fluid of asthmatic patients. Ohke M; Tada S; Nabe M; Matsuo K; Kataoka M; Harada M Acta Med Okayama; 2001 Apr; 55(2):83-9. PubMed ID: 11332203 [TBL] [Abstract][Full Text] [Related]
2. Fibronectin and hyaluronan in bronchoalveolar lavage fluid from young patients with chronic obstructive pulmonary diseases. Song WD; Zhang AC; Pang YY; Liu LH; Zhao JY; Deng SH; Zhang SY Respiration; 1995; 62(3):125-9. PubMed ID: 7569331 [TBL] [Abstract][Full Text] [Related]
3. Plasma fibronectin in asthmatic patients and its relation to asthma attack. Ohke M; Tada S; Kataoka M; Matsuo K; Nabe M; Harada M Acta Med Okayama; 2001 Apr; 55(2):91-6. PubMed ID: 11332204 [TBL] [Abstract][Full Text] [Related]
4. [Changes of extracellular matrix components in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis]. Zhao H; Chen B; Li Z Zhonghua Nei Ke Za Zhi; 1997 Jul; 36(7):457-60. PubMed ID: 10436946 [TBL] [Abstract][Full Text] [Related]
6. Increased chitinase expression and fungal-specific antibodies in the bronchoalveolar lavage fluid of asthmatic children. Goldman DL; Li X; Tsirilakis K; Andrade C; Casadevall A; Vicencio AG Clin Exp Allergy; 2012 Apr; 42(4):523-30. PubMed ID: 22092749 [TBL] [Abstract][Full Text] [Related]
7. Eicosanoids and lipocortin-1 in BAL fluid in asthma: effects of smoking and inhaled glucocorticoids. Van Hal PT; Overbeek SE; Hoogsteden HC; Zijlstra FJ; Murphy K; Oosterhoff Y; Postma DS; Guz A; Smith SF J Appl Physiol (1985); 1996 Aug; 81(2):548-55. PubMed ID: 8872617 [TBL] [Abstract][Full Text] [Related]
8. [An evaluation of fibronectin and IgG in bronchoalveolar lavage fluid of patients with interstitial lung diseases]. Zhao HW; Lu CJ; Li ZH Zhonghua Jie He He Hu Xi Za Zhi; 1994 Apr; 17(2):93-5, 127. PubMed ID: 7994776 [TBL] [Abstract][Full Text] [Related]
9. Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid. Meerschaert J; Kelly EA; Mosher DF; Busse WW; Jarjour NN Am J Respir Crit Care Med; 1999 Feb; 159(2):619-25. PubMed ID: 9927382 [TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor levels and localisation in human asthmatic bronchi. Olgart Höglund C; de Blay F; Oster JP; Duvernelle C; Kassel O; Pauli G; Frossard N Eur Respir J; 2002 Nov; 20(5):1110-6. PubMed ID: 12449162 [TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma. Torregrosa Paredes P; Esser J; Admyre C; Nord M; Rahman QK; Lukic A; Rådmark O; Grönneberg R; Grunewald J; Eklund A; Scheynius A; Gabrielsson S Allergy; 2012 Jul; 67(7):911-9. PubMed ID: 22620679 [TBL] [Abstract][Full Text] [Related]
12. Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Folkard SG; Westwick J; Millar AB Eur Respir J; 1997 Sep; 10(9):2097-104. PubMed ID: 9311510 [TBL] [Abstract][Full Text] [Related]
13. Concentration of endothelin in plasma and BALF fluid from asthmatic patients. Gawlik R; Jastrzebski D; Ziora D; Jarzab J J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():103-10. PubMed ID: 17072036 [TBL] [Abstract][Full Text] [Related]
14. Reduced production of interleukin 12 by interferon gamma primed alveolar macrophages from atopic asthmatic subjects. Plummeridge MJ; Armstrong L; Birchall MA; Millar AB Thorax; 2000 Oct; 55(10):842-7. PubMed ID: 10992536 [TBL] [Abstract][Full Text] [Related]
15. Quantification of fibronectin in bronchoalveolar lavage fluid and in lung parenchyma: differences between smokers and non-smokers. Menéndez R; Marco V; Rubio V; Solé A Respiration; 1995; 62(6):312-6. PubMed ID: 8552861 [TBL] [Abstract][Full Text] [Related]
16. Lipid mediator profiles differ between lung compartments in asthmatic and healthy humans. Larsson N; Lundström SL; Pinto R; Rankin G; Karimpour M; Blomberg A; Sandström T; Pourazar J; Trygg J; Behndig AF; Wheelock CE; Nording ML Eur Respir J; 2014 Feb; 43(2):453-63. PubMed ID: 24036245 [TBL] [Abstract][Full Text] [Related]
17. Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis. Jahnz-Rózyk KM; Kuna P; Pirozyńska E J Investig Allergol Clin Immunol; 1997; 7(4):254-9. PubMed ID: 9330191 [TBL] [Abstract][Full Text] [Related]
18. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Alam R; York J; Boyars M; Stafford S; Grant JA; Lee J; Forsythe P; Sim T; Ida N Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1398-404. PubMed ID: 8616572 [TBL] [Abstract][Full Text] [Related]
19. Detection of a novel macrophage-derived mucus secretagogue (MMS-68) in bronchoalveolar lavage fluid of patients with asthma. Sperber K; Chanez P; Bousquet J; Goswami S; Marom Z J Allergy Clin Immunol; 1995 Apr; 95(4):868-76. PubMed ID: 7722168 [TBL] [Abstract][Full Text] [Related]
20. Thalidomide inhibits alternative activation of macrophages in vivo and in vitro: a potential mechanism of anti-asthmatic effect of thalidomide. Lee HS; Kwon HS; Park DE; Woo YD; Kim HY; Kim HR; Cho SH; Min KU; Kang HR; Chang YS PLoS One; 2015; 10(4):e0123094. PubMed ID: 25905462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]